Integration of Stepped Care for Perinatal Mood and Anxiety Disorders Among Women Attending MCH Clinics
Perinatal mood and anxiety disorders (PMAD), defined as depression and anxiety during pregnancy or up to 1 year postpartum, account for substantial morbidity and mortality among birthing people globally especially in low- and middle-income countries. Several evidence-based interventions are recommended for identification and management of PMAD by non-specialist providers in resource-limited settings. This cluster-randomized trial seeks to evaluate the effect of a stepped-care intervention for screening and treatment of PMAD among perinatal women, on clinical and implementation outcomes.
• Pregnant and ≥28 weeks gestation
• Attending ANC care at the facility
• ≥14 years old
• Screen positive for PMAD symptoms (PHQ-2≥3 and/or GAD-2≥3)
• Willing to return to the MCH and PMTCT clinic for study visits